Physician profile
Erin Sullivan
NPI 1821442633
$13,274.50
in general payments reported to CMS, 2019-2025
32 companies · $2,087 in 2025
The $2,087 reported for 2025 was more than what 94% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,220 · 2022: $3,636 · 2023: $2,335 · 2024: $2,997 · 2025: $2,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,398 · Travel and Lodging: $2,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,397.53 |
| Travel and Lodging | $2,020.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,464.67 | 2021-2025 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $1,660.46 | 2021-2025 | |
| Amgen INC. | $1,146.05 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $794.91 | 2021-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $595.04 | 2021-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $551.83 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $534.51 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $503.26 | 2022-2025 | Verquvo |
| Cvrx, INC. | $396.78 | 2023-2025 | Barostim Neo System |
| Pfizer INC. | $304.56 | 2021-2025 | |
| Esperion Therapeutics, INC. | $266.36 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $245.97 | 2021-2023 | Jardiance |
| Alnylam Pharmaceuticals INC. | $228.90 | 2022-2023 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $213.55 | 2022-2023 | |
| Kiniksa Pharmaceuticals, LTD. | $171.60 | 2021-2023 | Arcalyst |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $145.29 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Philips North America LLC | $135.94 | 2022-2023 | |
| Edwards Lifesciences Corporation | $132.89 | 2025 | Sapien 3 Ultra Resilia |
| Biotronik INC. | $131.08 | 2024-2025 | Acticor 7 Vr-T Dx |
| Abbott Laboratories | $122.19 | 2022-2025 | Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Scpharmaceuticals INC. | $104.10 | 2024-2025 | |
| Medtronic, INC. | $86.62 | 2023-2025 | Linq II |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $80.50 | 2022 | |
| Irhythm Technologies, INC. | $78.55 | 2024 | Zio Xt Patch, Zio Monitor |
| Chiesi USA, INC. | $41.95 | 2023 | Kengreal |
| Arbor Pharmaceuticals, INC. | $27.96 | 2021 | |
| Sanofi-Aventis U.S. LLC | $26.76 | 2024 | |
| Impulse Dynamics (USA) INC. | $21.76 | 2023 | Optimizer |
| Mallinckrodt Hospital Products INC. | $17.83 | 2022 | |
| Lantheus Medical Imaging, INC. | $15.13 | 2023 | Definity |
| Nevro Corp. | $14.11 | 2024 | Senza |
| Convatec INC. | $13.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.